Holdings of JPMorgan Healthcare Leaders ETF
J.P. Morgan Exchange-Traded Fund Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 11.1M $ including 11M $ in equities, 98.9 %
- Positions
- 59 in 9 countries
- Top ten
- 46.6 % of net assets
- Filed on
- Apr 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 811 | 758K $ | 6.81 % |
| 2 | AbbVie Inc | 3,464 | 732K $ | 6.58 % |
| 3 | Johnson & Johnson | 3,001 | 689.8K $ | 6.20 % |
| 4 | UnitedHealth Group Inc | 1,751 | 648.7K $ | 5.83 % |
| 5 | AstraZeneca PLC | 2,677 | 507.9K $ | 4.57 % |
| 6 | Merck & Co Inc | 4,289 | 468.3K $ | 4.21 % |
| 7 | Bristol-Myers Squibb Co | 6,427 | 389.4K $ | 3.50 % |
| 8 | Thermo Fisher Scientific Inc | 740 | 354.4K $ | 3.19 % |
| 9 | Intuitive Surgical Inc | 719 | 329K $ | 2.96 % |
| 10 | CVS Health Corp | 3,618 | 301.3K $ | 2.71 % |
| 11 | Novo Nordisk A/S | 6,943 | 295.3K $ | 2.65 % |
| 12 | Roche Holding AG | 723 | 294.6K $ | 2.65 % |
| 13 | Argenx SE | 334 | 261.9K $ | 2.35 % |
| 14 | Hoya Corp | 1,400 | 261.4K $ | 2.35 % |
| 15 | Regeneron Pharmaceuticals, Inc. | 344 | 243.2K $ | 2.19 % |
| 16 | Boston Scientific Corp | 3,946 | 227.3K $ | 2.04 % |
| 17 | UCB SA | 803 | 218.6K $ | 1.97 % |
| 18 | Vertex Pharmaceuticals Inc | 510 | 218K $ | 1.96 % |
| 19 | Danaher Corp | 1,184 | 211.9K $ | 1.90 % |
| 20 | Edwards Lifesciences Corp | 2,435 | 203.3K $ | 1.83 % |
| 21 | McKesson Corp | 243 | 198.1K $ | 1.78 % |
| 22 | Stryker Corp | 562 | 177.1K $ | 1.59 % |
| 23 | Teva Pharmaceutical Industries Ltd | 4,466 | 157K $ | 1.41 % |
| 24 | Cardinal Health, Inc. | 796 | 153.5K $ | 1.38 % |
| 25 | Centene Corp | 2,739 | 147.1K $ | 1.32 % |
| 26 | Biogen Inc | 764 | 144.6K $ | 1.30 % |
| 27 | Zoetis Inc | 1,136 | 130.6K $ | 1.17 % |
| 28 | United Therapeutics Corp | 226 | 129.1K $ | 1.16 % |
| 29 | Lonza Group AG | 200 | 123K $ | 1.11 % |
| 30 | Novartis AG | 783 | 115.7K $ | 1.04 % |
| 31 | Fresenius SE & Co. KGaA | 2,383 | 115.4K $ | 1.04 % |
| 32 | IQVIA Holdings Inc | 726 | 115K $ | 1.03 % |
| 33 | Sartorius AG | 398 | 101.7K $ | 0.91 % |
| 34 | Spyre Therapeutics Inc | 1,327 | 98.8K $ | 0.89 % |
| 35 | Apogee Therapeutics Inc | 1,152 | 95.5K $ | 0.86 % |
| 36 | Ionis Pharmaceuticals Inc | 1,257 | 94K $ | 0.84 % |
| 37 | CG oncology Inc | 1,304 | 87K $ | 0.78 % |
| 38 | Ascendis Pharma A/S | 343 | 78.7K $ | 0.71 % |
| 39 | Align Technology Inc | 437 | 76.9K $ | 0.69 % |
| 40 | Immunome Inc | 3,351 | 76.9K $ | 0.69 % |
| 41 | Dyne Therapeutics Inc | 4,266 | 74.9K $ | 0.67 % |
| 42 | Dexcom Inc | 1,196 | 71.2K $ | 0.64 % |
| 43 | Neurocrine Biosciences Inc | 533 | 70.2K $ | 0.63 % |
| 44 | Genmab A/S | 265 | 70.2K $ | 0.63 % |
| 45 | Daiichi Sankyo Co Ltd | 4,200 | 68.2K $ | 0.61 % |
| 46 | Convatec Group PLC | 23,481 | 67.3K $ | 0.61 % |
| 47 | Cigna Group/The | 231 | 67.1K $ | 0.60 % |
| 48 | Medtronic PLC | 808 | 65.4K $ | 0.59 % |
| 49 | Alumis Inc | 2,446 | 60.4K $ | 0.54 % |
| 50 | Nuvalent Inc | 584 | 58.6K $ | 0.53 % |
| 51 | Bio-Techne Corp | 843 | 46.6K $ | 0.42 % |
| 52 | Sionna Therapeutics Inc | 1,201 | 46.5K $ | 0.42 % |
| 53 | Disc Medicine Inc | 636 | 41.9K $ | 0.38 % |
| 54 | Alnylam Pharmaceuticals Inc | 112 | 34.7K $ | 0.31 % |
| 55 | Viridian Therapeutics Inc | 2,323 | 31.3K $ | 0.28 % |
| 56 | Evommune Inc | 1,260 | 30K $ | 0.27 % |
| 57 | Xenon Pharmaceuticals Inc | 535 | 30K $ | 0.27 % |
| 58 | HCA Healthcare Inc | 68 | 29.5K $ | 0.27 % |
| 59 | Genmab A/S | 523 | 13.9K $ | 0.12 % |
Sector breakdown
- Health care 83.0 %
- Unattributed 17.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 75.9 %
- EUR 6.3 %
- GBP 5.2 %
- CHF 4.8 %
- DKK 3.3 %
- JPY 3.0 %
- ILS 1.4 %
The quoted currency of each line, as declared.
Country breakdown
- United States 75.5 %
- United Kingdom 5.2 %
- Switzerland 4.8 %
- Belgium 4.4 %
- Denmark 3.4 %
- Japan 3.0 %
- Germany 2.0 %
- Israel 1.4 %
- Canada 0.3 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 43 | 8.3M $ | 75.45 % |
| 2 | United Kingdom | 2 | 575.2K $ | 5.23 % |
| 3 | Switzerland | 3 | 533.3K $ | 4.84 % |
| 4 | Belgium | 2 | 480.6K $ | 4.37 % |
| 5 | Denmark | 3 | 379.4K $ | 3.45 % |
| 6 | Japan | 2 | 329.7K $ | 2.99 % |
| 7 | Germany | 2 | 217.1K $ | 1.97 % |
| 8 | Israel | 1 | 157K $ | 1.43 % |
| 9 | Canada | 1 | 30K $ | 0.27 % |
Cite this page
Titelia. "Holdings of JPMorgan Healthcare Leaders ETF". https://titelia.com/en/funds/S000080528